Osterweis Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$8.75M |
| 2 |
Adobe
ADBE
|
+$7.75M |
| 3 |
Duolingo
DUOL
|
+$7.16M |
| 4 |
SKX
Skechers
SKX
|
+$7.16M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$6.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$16.8M |
| 2 |
Microsoft
MSFT
|
+$9.45M |
| 3 |
Ametek
AME
|
+$8.24M |
| 4 |
Insulet
PODD
|
+$7.79M |
| 5 |
RBC Bearings
RBC
|
+$7.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.97% |
| 2 | Healthcare | 16.08% |
| 3 | Industrials | 11.11% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Consumer Staples | 7.57% |
Similar funds
Osterweis Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Osterweis Capital Management held 208 positions worth $1.7B, up 8.1% from $1.58B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Osterweis Capital Management withdrew a net $195M in Q1 2024, closing 18 positions and reducing 75 holdings. Its most notable exit was Insulet, an estimated $7.79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Osterweis Capital Management opened a new position in Bio-Techne worth $8.61M.
- Osterweis Capital Management's largest Q1 2024 buy was Bio-Techne: 122,328 shares worth $8.61M.
- Osterweis Capital Management added most to Adobe in Q1 2024, an estimated $7.75M increase.
- Osterweis Capital Management's biggest Q1 2024 reduction was Kenvue, cutting an estimated $16.8M.
- Osterweis Capital Management fully exited Insulet in Q1 2024, selling an estimated $7.79M.
- Osterweis Capital Management's ten largest holdings make up 33% of its $1.7B portfolio in Q1 2024.
- Osterweis Capital Management opened 16 new positions and closed 18 in Q1 2024.
- Osterweis Capital Management's portfolio value rose 8.1% quarter-over-quarter to $1.7B.
Based on Osterweis Capital Management's 13F filing for Q1 2024, filed 15 May 2024.